Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on June 1, 2026

Jun. 1, 2026

Oak Hill Bio Raises $32.5 Million Series A Financing to Advance Antisense Oligonucleotide Therapy Rugonersen to Phase 3 Study in Angelman Syndrome

Indeterminate GlobeNewswire

Jun. 1, 2026

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

How Advanced Drug Delivery Could Improve Existing Cancer Treatments

Indeterminate GlobeNewswire

Jun. 1, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Indeterminate GlobeNewswire

Jun. 1, 2026

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders

Indeterminate GlobeNewswire

Jun. 1, 2026

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Compounding Award Recipients Celebrated at PCCA CONNEXT: Canadian Compounding Conference 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

LifeMD Appoints Umesh Sripad as Chief Technology Officer

Indeterminate GlobeNewswire

Jun. 1, 2026

NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Jun. 1, 2026

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

Dr. Falk Pharma and Renexxion Proceed to Late-Stage Development of Naronapride, Moving Towards Approval in the US and Europe, Following Positive Global Phase 2b Results in Gastroparesis

Indeterminate GlobeNewswire

Jun. 1, 2026

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 1, 2026

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Solid Biosciences to Participate at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Jun. 1, 2026

MOVATI Athletic Introduces Four New Certified HYROX Training Clubs

Indeterminate GlobeNewswire